Hope Rugo

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

Ayalew Tefferi, Hagop Kantarjian, S. Vincent Rajkumar et al. · Mayo Clinic Proceedings · 2015 · 144 citations · Full text

High Price, Healthcare Value, Health Economics +12

Abstract GS1-11: Sacituzumab Govitecan (SG) vs Treatment of Physician’s Choice (TPC): Efficacy by Trop-2 Expression in the TROPiCS-02 Study of Patients (Pts) With HR+/HER2– Metastatic Breast Cancer (mBC)

Hope Rugo, Aditya Bardia, Frederik Marmé et al. · Cancer Research · 2023 · 21 citations

Breast Oncology, Abstract Gs1-11, Sacituzumab Govitecan +15

Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO-2 Phase III Trial

J. Baselqa, Mario Campone, Tarek Sahmoud et al. · European Journal of Cancer · 2011 · 19 citations

Breast Oncology, Medicine, Pharmacology +9

Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer.

HL McArthur, Hope Rugo, Benjamin Nulsen et al. · Cancer Research · 2009 · 14 citations

Heart Failure, Breast Oncology, Cardiovascular Pharmacology +22

Abstract GS5-03: Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL

Claudine Isaacs, Rita Nanda, Jo Chien et al. · Cancer Research · 2023 · 14 citations

Breast Oncology, Cemiplimab 350, Immunology +19